Announcements - Search results

Search results: Company announcements for
IMMURON LIMITED (IMC)
Released between 01/01/2017 and 31/12/2017

Didn't find the announcement you were after? Search again.

Announcements released as IMC
Date Price sens. Headline
22/12/2017
6:36 PM
  Form 604 - Change in Substantial Shareholding (Grandlodge)
3 pages 46.3KB
22/12/2017
6:36 PM
  Appendix 3Y - Change of Director's Interest Notice (SA)
2 pages 45.1KB
22/12/2017
6:33 PM
  Appendix 3Y - Change of Director's Interest Notice (PA)
2 pages 44.9KB
14/12/2017
2:55 PM
  Appendix 3B
10 pages 258.4KB
22/11/2017
12:35 PM
  Van Leeuwenhoeck Institute Updates Immuron Research Coverage
2 pages 187.9KB
14/11/2017
10:03 AM
asterix Immuron Granted US Patent for NASH Treatment
2 pages 219.5KB
13/11/2017
6:34 PM
  Results of 2017 Annual General Meeting
1 page 284.5KB
09/11/2017
9:54 AM
asterix Immuron Successfully Completes NASH Phase II Clinical Study
3 pages 224.5KB
08/11/2017
3:00 PM
asterix Travelan Experiences Strong Q1 FY2018 Sales Growth
2 pages 337.7KB
03/11/2017
12:25 PM
  Immuron Lodges Form 20F USA Annual Report
146 pages 2.0MB
18/10/2017
2:18 PM
  Notice of Annual General Meeting & Proxy Form
22 pages 1.2MB
10/10/2017
10:05 AM
  Appendix 3Y - Change of Director's Interest Notice (PA)
2 pages 126.3KB
28/09/2017
5:20 PM
  Corporate Governance Statement
8 pages 537.8KB
28/09/2017
5:20 PM
  Appendix 4G
10 pages 414.1KB
28/09/2017
5:19 PM
  Annual Report
82 pages 12.5MB
11/09/2017
9:58 AM
  Appendix 3Y - Change of Director's Interest Notice (DP)
2 pages 499.7KB
08/09/2017
4:57 PM
  Form 605 - Ceasing to be Substantial Shareholder (Retzos)
2 pages 589.3KB
31/08/2017
3:23 PM
asterix Appendix 4E Preliminary Final Report (30 June 2017)
21 pages 1.1MB
28/08/2017
9:57 AM
asterix Immuron Opens Clinical Site to Commence C.Diff CDI Study
3 pages 976.4KB
28/08/2017
8:16 AM
  Appendix 3Y - Change of Director's Interest Notice (PA)
2 pages 499.8KB
17/08/2017
3:08 PM
  Updated Immuron Securities Trading Policy
7 pages 127.5KB
15/08/2017
4:17 PM
  Appendix 3Y - Change of Director's Interest Notice (PA)
2 pages 43.0KB
15/08/2017
2:42 PM
  Immuron Commences US Non-Deal Institutional Investor Roadshw
43 pages 5.2MB
09/08/2017
9:52 AM
asterix Immuron Approved to Commence Clinical Study in C.Difficile
3 pages 118.8KB
08/08/2017
3:06 PM
asterix Immuron to Present C.difficile Data at ClostPath 2017 Confer
3 pages 360.1KB
08/08/2017
1:42 PM
  Appendix 3Y - Change of Director's Interest Notice (PA)
2 pages 370.5KB
07/08/2017
10:49 AM
  Immuron Presents NASH Interim-Results at BioShares Conferenc
12 pages 1.5MB
03/08/2017
12:27 PM
asterix Immuron Announces Management Changes
2 pages 341.0KB
28/07/2017
2:48 PM
  Appendix 3B
11 pages 710.8KB
13/07/2017
10:58 AM
asterix Success of NASH Phase II Interim Analysis Explained Further
4 pages 375.9KB
10/07/2017
9:45 AM
asterix NASH PhaseII Interim Analysis Reveals Improved Liver Enzymes
3 pages 351.2KB
03/07/2017
10:41 AM
asterix Pre-Clinical C. difficile Infection Results Paper Published
3 pages 357.4KB
03/07/2017
9:20 AM
  Appendix 3Y - Change of Director's Interest Notice (RS)
2 pages 43.1KB
26/06/2017
9:50 AM
  Change of address
2 pages 226.8KB
23/06/2017
11:01 AM
  Appendix 3B - Issuance of Options (ESOP)
11 pages 714.8KB
20/06/2017
4:15 PM
  Ceasing to be a substantial holder
2 pages 769.4KB
20/06/2017
2:08 PM
  Change in substantial holding
3 pages 275.9KB
20/06/2017
2:07 PM
  Change in substantial holding
3 pages 292.7KB
20/06/2017
2:07 PM
  Change of Director's Interest Notice
2 pages 386.4KB
20/06/2017
2:05 PM
  Change of Director's Interest Notice
2 pages 372.9KB
20/06/2017
9:16 AM
  Change of Director's Interest Notice
2 pages 382.7KB
16/06/2017
8:24 AM
  Appendix 3B - Allotment of NASDAQ Listing
11 pages 717.0KB
09/06/2017
9:49 AM
asterix IMC Prices US IPO and NASDAQ Listing Raising USD$6.1M
3 pages 1.2MB
08/06/2017
9:52 AM
asterix Trading Halt
2 pages 306.0KB
02/06/2017
10:03 AM
asterix Travelan Increases Industry Presence - Conf & Sales Update
3 pages 1.2MB
01/06/2017
10:01 AM
asterix Immuron Secures $1.5M R&D Cash Advance Loan Funding
3 pages 1.1MB
01/06/2017
9:19 AM
asterix NASDAQ Listing on Hold Pending NASH Interim Analysis Results
3 pages 1.1MB
30/05/2017
9:45 AM
asterix Trading Halt
2 pages 305.7KB
16/05/2017
12:03 PM
asterix IMC Expands Agreement with US Army-3 Additional Therapeutics
3 pages 1.2MB
10/05/2017
10:43 AM
asterix Completion of Manufacturing of Drug Product for C-Diff Trial
3 pages 1.2MB
09/05/2017
1:06 PM
  Immuron - New Investor Corporate Presentation (May 2017)
39 pages 7.0MB
09/05/2017
1:02 PM
asterix IMC Form F1 - US Registration Statement (Prelim. Prospectus)
200 pages 1.1MB
09/05/2017
12:37 PM
  Immuron Files Amended Form F-1 and New Investor Presentation
2 pages 1.1MB
05/05/2017
8:59 AM
  Form 604 - Change in Substantial Shareholding (Authentics)
3 pages 106.3KB
05/05/2017
8:58 AM
  Form 603 - Initial Substantial Shareholder (Authentics)
3 pages 104.2KB
18/04/2017
10:34 AM
asterix Positive Results of IMM-124E in Acute Colitis Studies
3 pages 1.3MB
11/04/2017
11:49 AM
  Immuron Update on US Listing - Proceeding as Planned
3 pages 424.9KB
11/04/2017
9:56 AM
  Immuron Update on Listing - Process Proceeding as Planned
4 pages 108.4KB
10/04/2017
4:56 PM
  Immuron Files Amended Form F-1 with the SEC
206 pages 2.1MB
07/04/2017
10:34 AM
  Director Appointment - Prof. Ravi Savarirayan
3 pages 256.6KB
06/04/2017
12:47 PM
asterix Close of Recruitment of Phase II NASH Trial
3 pages 428.9KB
28/02/2017
6:04 PM
asterix Appendix 4D - Half Year Report and Accounts - Dec 2016
24 pages 1.2MB
20/02/2017
11:44 AM
asterix Immuron Completes Phase II NASH Clinical Trial Recruitment
3 pages 1.1MB
09/02/2017
1:48 PM
  Immuron Files Amended Form F-1 with the SEC
190 pages 1.7MB
06/02/2017
12:22 PM
asterix First Patient in Pediatric Fatty-Liver Phase II Trial
2 pages 436.7KB
19/01/2017
11:09 AM
asterix NASH MOA Study commences with SanyalBio & Duke University
3 pages 469.8KB
18/01/2017
9:45 AM
  European/US Analyst - Immuron Moving to Forefront in NASH
2 pages 87.9KB
09/01/2017
12:11 PM
  Gilead Pays $100M NASH Related Milestone to Phenex
2 pages 114.5KB
06/01/2017
12:01 PM
  JNJ, BMS and Novartis Complete NASH Asset Transactions
2 pages 102.7KB

Useful Information

Previous codes used by this company

  • ANX changed to IMC

Other companies that have used the code 'IMC'

  • INTERNATIONAL MINING CORPORATION NL - previously known as
  • INTERNATIONAL MINING CORPORATION N.L.

view available announcements for this company

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.